|
1
|
Stiefel HC, Kopplin LJ, Albini T, Chang M, Vegunta S, Suhler EB. Treatment of Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A Retrospective Chart Review. Ocul Immunol Inflamm 2019; 29:566-571. [PMID: 31743052 DOI: 10.1080/09273948.2019.1687729] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Purpose: To determine the efficacy of pegylated interferon alfa-2A in the treatment of refractory inflammatory cystoid macular edema (CME)Methods: Retrospective chart reviewResults: Treatment with pegylated interferon alfa-2A led to an improvement in CME in all eyes of seven included patients, with a mean decrease in CMT from 478 µm to 310 µm (p < .05). The vision in one patient did not improve due to preexisting retinal atrophy. All other eyes showed improvement in vision, with a mean improvement in best LogMAR visual acuity from +0.59 to +0.28 (p < .05). The treatment effect was sustained with low-dose treatment every 2 weeks or less in the majority of patients. Two patients who stopped interferon treatment given flu-like symptoms and intolerable rash, respectively, showed rapid recurrence of CME.Conclusions: Weekly administration of pegylated interferon alfa-2A is an effective treatment for refractory inflammatory CME, though side effects may limit tolerability in some patients.
Collapse
Affiliation(s)
- Hillary C Stiefel
- Department of Ophthalmology, Portland VA Health Care System, Portland, OR, USA.,Departments of Ophthalmology (Casey Eye Institute), Oregon Health & Science University, Portland, OR, USA
| | - Laura J Kopplin
- Department of Ophthalmology, Portland VA Health Care System, Portland, OR, USA.,Departments of Ophthalmology (Casey Eye Institute), Oregon Health & Science University, Portland, OR, USA.,Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, WI, USA
| | - Thomas Albini
- Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA
| | - Michael Chang
- Department of Ophthalmology, Portland VA Health Care System, Portland, OR, USA.,Hospital and Specialty Medicine, Oregon Health & Science University, Portland, OR, USA
| | - Sravanthi Vegunta
- Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.,John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA
| | - Eric B Suhler
- Department of Ophthalmology, Portland VA Health Care System, Portland, OR, USA.,Departments of Ophthalmology (Casey Eye Institute), Oregon Health & Science University, Portland, OR, USA
| |
Collapse
|